MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Remolding a Leader

Originally Published MX January/February 2003


Interview by Steve Halasey

Martin D. Madaus, 
president and CEO 
of Roche Diagnostics, 
on leadership 
in the market--
and in the boardroom.

Leadership counts--and not just on the bottom line. Company leadership can influence the direction of a marketplace and its investors, making available resources that would otherwise have gone into other sectors or industries. And personal leadership can encourage companies to take on challenges well beyond those of an already competitive marketplace.

But don't take our word for it. Ask Martin D. Madaus, president and CEO of Roche Diagnostics Corp. (Indianapolis), the leader in the global market for in vitro diagnostics (IVDs). Rising through the ranks at Boehringer Mannheim (acquired by Roche in 1997), Madaus took over the helm of the company in January 2000. He arrived with a clear notion of the kind of company he wanted to lead, and rapidly set about putting his changes in motion.

Madaus's efforts have paid off in the company's bottom line--and elsewhere. During the past year, Roche has repeatedly grabbed top honors at a wide variety of awards presentations. In December, the company's e-business unit received

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.